ArticleFrontiers in endocrinology2025
Analysis of risk factors and construction of a predictive model for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Treatment strategies for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis: a narrative review.Gland surgery · 2026Review
- Posterior minimal extrathyroidal extension as an independent risk factor for lateral lymph node metastasis in papillary thyroid carcinoma: a retrospective study based on a nomogram prediction model.Frontiers in endocrinology · 2026Article
- Predictive factors for re-recurrence in papillary thyroid carcinoma following reoperation: a retrospective analysis.Gland surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to investigate the risk factors associated with contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma and to develop a corresponding prediction model to enhance early detection and clinical management of occult carcinoma. Methods: The clinical data of 430 patients who underwent total thyroidectomy for unilateral papillary thyroid carcinoma at Xiangyang Central Hospital between January 2021 and December 2022 were collected. Univariate and multivariate logistic regression analyses were performed to identify risk factors for contralateral occult cancer in patients with unilateral thyroid carcinoma. A prediction model was established, and the diagnostic value of the model was assessed using calibration curves and decision curve analysis. Results: The results of univariate logistic regression analysis indicated that tumor diameter, tumor location, multifocality, presence of contralateral benign nodules, and lateral neck lymph node metastasis were risk factors for contralateral occult carcinoma in patients with unilateral thyroid cancer (P < 0.05). Multivariate logistic regression analysis further showed that a tumor diameter >1 cm, proximity of the tumor to the isthmus, multifocality, presence of contralateral benign nodules, and lateral neck lymph node metastasis were independent risk factors for contralateral occult carcinoma in unilateral thyroid cancer (P < 0.01). A risk nomogram model was developed based on these five risk factors, with areas under the curve (AUC) of 0.921 and 0.96 for the training and validation sets, respectively. The calibration curve demonstrated good consistency, and decision curve analysis indicated that the model had a high level of net benefit. Conclusion: A tumor diameter >1 cm, proximity of the tumor to the isthmus, lateral neck lymph node metastasis, presence of contralateral benign nodules, and multifocality are independent risk factors for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma. The predictive model developed in this study demonstrates strong predictive ability for the occurrence of contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.